Screening for Colorectal Cancer

What is Colorectal Cancer?

The colon is the longest part of the large intestine and the rectum is the last few inches of the large intestine before the anus. Polyps which are benign lumps may form on the inner wall of the colon and rectum. However, certain type of polyps may develop into cancer and should be removed if they are detected. This cancer is known as the cancer of the colon or rectum.

Colorectal Cancer is the third most common cancer in the world amongst men and second most common cancer amongst women. In 2018, there were 1.8 million new cases diagnosed. Both men and women above the age of 50 years are encouraged to do yearly Colorectal Cancer screening which can aid in the early detection and treatment of polyps.

What is CRCProtect™?

CRCProtect™ is a non-invasive blood test for the early detection of colorectal cancer and precancerous lesions which detects and quantifies Circulating Tumour Cells (CTCs).

CTCs are cells that are shed by the primary tumour into the bloodstream. Unlike Faecal Immunochemical Test which detects small amounts of blood in the faeces, CRCProtect™ detects as minute as 1 CTC per 10 billion blood cells to come up with the risk score of an individual having colorectal cancer.

Why CRCProtect™?

As CRCProtect™ is a non-invasive blood test, individuals may discuss with their doctors to have CRCProtect™ incorporated into their regular health screening. CRCProtect™ eliminates the need for bowel preparation associated with a screening colonoscopy and compliance issues associated with faecal immunochemical testing.

Who can benefit from CRCProtect™?

• Individuals who are over 50 years of age
• Individuals with strong family history of colon or rectum cancer
• Individuals with personal history of colon polyps
• Individuals with a history of ulcers in the large intestine lining or Crohn’s disease
• Individuals who smoke or have a diet high in fats and low in fruits and vegetables

Breast Cancer, the top cancer among women, affects approximately 1 in 11 women in Singapore.Some of the risk factors for Breast Cancer include:

1. Gender – Females are more likely than men to develop Breast Cancer
2. Increasing age
3. Personal medical history of breast conditions
4. Family history of direct family members having breast cancer
5. Genetics
6. Early menses before the age of 12 years old
7. Late menopausal age
8. Delivery of first child after age 30
9. Postmenopausal hormone therapy

Sexually Transmitted Diseases (STD), otherwise known as Venereal Diseases are infections that pass from one individual to another through sexual contact.

Fusion offers a comprehensive screen for both males and females in a discreet environment with their privacy in mind.

• Males S$350 Nett
• Females S$490 Nett